PSEC

Prospect is an externally managed BDC lending to private middle-market companies, and the FY2025 numbers show a business eroding its own capital. Net income swung to a -$470M loss (EPS -$1.35) from +$263M a year earlier — the second loss in three years (FY2023 was -$102M) — driving ROE to -15.7% and pushing accumulated retained earnings to -$1.25B. Stockholders' equity fell 19.5% to $2.99B; against 462M shares that is book/NAV of roughly $6.47, so at $2.32 the stock trades near 0.36x NAV. That ~64% discount is the bull case, but a discount that wide and persistent is the market's verdict on asset quality and management, not a mispricing waiting to close.

The quality flags compound. Shares grew 7.8% even as the stock sat far below NAV — for a BDC, issuing equity below book is directly value-destructive to existing holders and helps explain the NAV slide. The dividend was already cut 11.3% ($264M paid), yet on a ~$2.32 price the distribution still implies a low-20s% yield, the classic signature of a payout the market expects to fall again. Cash & equivalents dropped 40.9% to a thin $50.8M against $2.09B of long-term debt. The one genuine positive is operating cash flow of $523M (up 86.9%), which more than covers the $264M dividend — so the distribution is not unfunded today — but the GAAP losses are coming from portfolio markdowns/credit deterioration, and that is what erodes NAV regardless of cash coverage.